A detailed history of Abound Wealth Management transactions in Vericel Corp stock. As of the latest transaction made, Abound Wealth Management holds 4 shares of VCEL stock, worth $226. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4
Previous 7 42.86%
Holding current value
$226
Previous $322,000 47.52%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$42.25 - $53.56 $126 - $160
-3 Reduced 42.86%
4 $169,000
Q2 2023

Aug 08, 2024

BUY
$29.0 - $38.37 $203 - $268
7 New
7 $263,000

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.68B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Abound Wealth Management Portfolio

Follow Abound Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abound Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Abound Wealth Management with notifications on news.